Search Results - "Fujioka, T."

Refine Results
  1. 1

    One year of musical training affects development of auditory cortical-evoked fields in young children by Fujioka, Takako, Ross, Bernhard, Kakigi, Ryusuke, Pantev, Christo, Trainor, Laurel J.

    Published in Brain (London, England : 1878) (01-10-2006)
    “…Auditory evoked responses to a violin tone and a noise-burst stimulus were recorded from 4- to 6-year-old children in four repeated measurements over a 1-year…”
    Get full text
    Journal Article
  2. 2

    CD133 is a positive marker for a distinct class of primitive human cord blood-derived CD34-negative hematopoietic stem cells by Takahashi, M, Matsuoka, Y, Sumide, K, Nakatsuka, R, Fujioka, T, Kohno, H, Sasaki, Y, Matsui, K, Asano, H, Kaneko, K, Sonoda, Y

    Published in Leukemia (01-06-2014)
    “…The identification of human CD34-negative (CD34 − ) hematopoietic stem cells (HSCs) provides a new concept for the hierarchy in the human HSC compartment…”
    Get full text
    Journal Article
  3. 3

    Risk and prevention of graft failure in patients with preexisting donor-specific HLA antibodies undergoing unmanipulated haploidentical SCT by Yoshihara, S, Maruya, E, Taniguchi, K, Kaida, K, Kato, R, Inoue, T, Fujioka, T, Tamaki, H, Ikegame, K, Okada, M, Soma, T, Hayashi, K, Fujii, N, Onuma, T, Kusunoki, Y, Saji, H, Ogawa, H

    Published in Bone marrow transplantation (Basingstoke) (01-04-2012)
    “…A role of donor-specific HLA antibodies (DSA) in graft failure after SCT has been suggested, but the relevance of DSA in unmanipulated haploidentical SCT…”
    Get full text
    Journal Article
  4. 4

    A phase I/II study of cancer peptide vaccine S-288310 in patients with advanced urothelial carcinoma of the bladder by Obara, W., Eto, M., Mimata, H., Kohri, K., Mitsuhata, N., Miura, I., Shuin, T., Miki, T., Koie, T., Fujimoto, H., Minami, K., Enomoto, Y., Nasu, T., Yoshida, T., Fuse, H., Hara, I., Kawaguchi, K., Arimura, A., Fujioka, T.

    Published in Annals of oncology (01-04-2017)
    “…S-288310, a cancer peptide vaccine composed of two HLA-A*24:02-restricted peptides derived from two oncoantigens, DEP domain-containing 1 (DEPDC1) and M-phase…”
    Get full text
    Journal Article
  5. 5

    Differential effects of prenatal stress on the morphological maturation of hippocampal neurons by Fujioka, A., Fujioka, T., Ishida, Y., Maekawa, T., Nakamura, S.

    Published in Neuroscience (01-01-2006)
    “…The present study was designed to clarify an intensity-dependent effect of prenatal stress on the morphological development of hippocampal neurons in rats. In…”
    Get full text
    Journal Article
  6. 6
  7. 7

    Attenuated relationship between salivary oxytocin levels and attention to social information in adolescents and adults with autism spectrum disorder: a comparative study by Fujioka, T, Fujisawa, T X, Inohara, K, Okamoto, Y, Matsumura, Y, Tsuchiya, K J, Katayama, T, Munesue, T, Tomoda, A, Wada, Y, Kosaka, H

    Published in Annals of general psychiatry (05-06-2020)
    “…Previous research studies have assessed the relationship between attention to social information and peripheral (e.g., plasma and salivary) oxytocin (OT)…”
    Get full text
    Journal Article
  8. 8

    Genome-wide analysis of DNA copy number alterations and gene expression in gastric cancer by Tsukamoto, Y, Uchida, T, Karnan, S, Noguchi, T, Nguyen, LT, Tanigawa, M, Takeuchi, I, Matsuura, K, Hijiya, N, Nakada, C, Kishida, T, Kawahara, K, Ito, H, Murakami, K, Fujioka, T, Seto, M, Moriyama, M

    Published in The Journal of pathology (01-12-2008)
    “…Genomic copy number aberrations (CNAs) are believed to play a major role in the development and progression of human cancers. Although many CNAs have been…”
    Get full text
    Journal Article
  9. 9

    Involvement of upregulation of DEPDC1 (DEP domain containing 1) in bladder carcinogenesis by KANEHIRA, M, HARADA, Y, TAKATA, R, SHUIN, T, MIKI, T, FUJIOKA, T, NAKAMURA, Y, KATAGIRI, T

    Published in Oncogene (27-09-2007)
    “…In an attempt to disclose mechanisms of bladder carcinogenesis and discover novel target molecules for development of treatment, we applied a cDNA microarray…”
    Get full text
    Journal Article
  10. 10

    Stiripentol for the treatment of super‐refractory status epilepticus with cross‐sensitivity by Uchida, Y., Terada, K., Madokoro, Y., Fujioka, T., Mizuno, M., Toyoda, T., Kato, D., Matsukawa, N.

    Published in Acta neurologica Scandinavica (01-04-2018)
    “…Background Cross‐sensitivity of rash has been reported between various antiepileptic drugs (AEDs). However, few studies have determined the frequency and…”
    Get full text
    Journal Article
  11. 11

    Quantitative tomography of hydrogen precharged and uncharged Al-Zn-Mg-Cu alloy after tensile fracture by Gupta, C., Toda, H., Fujioka, T., Kobayashi, M., Hoshino, H., Uesugi, K., Takeuchi, A., Suzuki, Y.

    “…Quantitative tomography is carried out on datasets derived from tensile fracture sample of electrochemically precharged Al-Zn-Mg-Cu alloy in the underaged…”
    Get full text
    Journal Article
  12. 12

    Genetics of Behçet disease inside and outside the MHC by Meguro, Akira, Inoko, Hidetoshi, Ota, Masao, Katsuyama, Yoshihiko, Oka, Akira, Okada, Eiichi, Yamakawa, Ryoji, Yuasa, Takenosuke, Fujioka, Toshihiko, Ohno, Shigeaki, Bahram, Seiamak, Mizuki, Nobuhisa

    Published in Annals of the rheumatic diseases (01-04-2010)
    “…Behçet disease (BD) is a rare, chronic, systemic, inflammatory disorder characterised by recurrent ocular, genital and skin lesions. Although its aetiology is…”
    Get more information
    Journal Article
  13. 13
  14. 14
  15. 15

    Frequency of CD4+FOXP3+ regulatory T-cells at early stages after HLA-mismatched allogeneic hematopoietic SCT predicts the incidence of acute GVHD by Fujioka, T, Tamaki, H, Ikegame, K, Yoshihara, S, Taniguchi, K, Kaida, K, Kato, R, Inoue, T, Nakata, J, Ishii, S, Soma, T, Okada, M, Ogawa, H

    Published in Bone marrow transplantation (Basingstoke) (01-06-2013)
    “…Acute GVHD (aGVHD) is a major obstacle to allogeneic hematopoietic SCT (alloHSCT). Although it is thought that aGVHD is initiated in secondary lymphoid organs…”
    Get full text
    Journal Article
  16. 16

    Ultrasonographic evaluation of the caudal vena cava in dogs with right-sided heart disease by Fujioka, T., Nakamura, K., Minamoto, T., Tsuzuki, N., Yamaguchi, J., Hidaka, Y.

    Published in Journal of veterinary cardiology (01-04-2021)
    “…In humans with impaired right-sided cardiac function, the caudal vena cava (CVC) diameter serves as a marker of venous congestion. This study aimed to…”
    Get full text
    Journal Article
  17. 17

    Million-year lag times in a post-orogenic sediment conveyor by Fülöp, R.-H., Codilean, A. T., Wilcken, K. M., Cohen, T. J., Fink, D., Smith, A. M., Yang, B., Levchenko, V. A., Wacker, L., Marx, S. K., Stromsoe, N., Fujioka, T., Dunai, T. J.

    Published in Science advances (01-06-2020)
    “…Reworking of old sediment in the Murray-Darling implies alteration of environmental signals traveling from source to sink. Understanding how sediment transport…”
    Get full text
    Journal Article
  18. 18

    Incidence of extramedullary relapse after haploidentical SCT for advanced AML/myelodysplastic syndrome by Yoshihara, S, Ikegame, K, Kaida, K, Taniguchi, K, Kato, R, Inoue, T, Fujioka, T, Tamaki, H, Okada, M, Soma, T, Ogawa, H

    Published in Bone marrow transplantation (Basingstoke) (01-05-2012)
    “…Extramedullary (EM) relapse of leukemia after allo-SCT in patients with AML/myelodysplastic syndrome has been increasingly reported. The reduced effectiveness…”
    Get full text
    Journal Article
  19. 19

    Cancer peptide vaccine therapy developed from oncoantigens identified through genome-wide expression profile analysis for bladder cancer by Obara, Wataru, Ohsawa, Ryuji, Kanehira, Mitsugu, Takata, Ryo, Tsunoda, Takuya, Yoshida, Koji, Takeda, Kazuyoshi, Katagiri, Toyomasa, Nakamura, Yusuke, Fujioka, Tomoaki

    Published in Japanese journal of clinical oncology (01-07-2012)
    “…The field of cancer vaccine therapy is currently expected to become the fourth option in the treatment of cancer after surgery, chemotherapy and radiation…”
    Get full text
    Journal Article
  20. 20